Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propyl propane thiosulfonate (PTSO) is a naturally occurring organosulfur compound derived from *Allium* species, such as onions (*Allium cepa*) and garlic (*Allium sativum*). It is primarily utilized as a functional feed additive in veterinary medicine and aquaculture due to its broad-spectrum antimicrobial, anti-inflammatory, and immunomodulatory properties. PTSO has demonstrated significant efficacy in reducing pathogenic bacterial populations, including *Salmonella*, *Escherichia coli*, and *Vibrio*, while promoting the growth of beneficial gut bacteria such as *Lactobacillus* and *Bifidobacterium*. Beyond its antimicrobial role, PTSO exhibits antioxidant activity through the activation of the Nrf2 pathway and reduces the expression of pro-inflammatory cytokines like IL-6 and IL-8. Research is also investigating its potential application in human health for the management of metabolic syndrome, obesity, and the prevention of colorectal cancer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propyl propane thiosulfonate.